Document Detail

Review: Ototoxic Characteristics of Platinum Antitumor Drugs.
MedLine Citation:
PMID:  23044998     Owner:  NLM     Status:  Publisher    
Cisplatin, carboplatin, nedaplatin, and oxaliplatin are widely used in contemporary oncology; however, their ototoxic and neurotoxic side effects are quite different as discussed in this review. Cisplatin is considered the most ototoxic, but despite its reputation, the magnitude of hair cell loss that occurs with a single, large drug bolus is limited and confined to the base of the cochlea. For all of these platinum compounds, a major factor limiting damage is drug uptake from stria vascularis into the cochlear fluids. Disrupting the blood-labyrinth barrier with diuretics or noise exposure enhances drug uptake and significantly increases the amount of damage. Combined treatment with ethacrynic acid (a loop diuretic) and cisplatin results in rapid apoptotic hair cell death characterized by upregulation of initiator caspase-8 and membrane death receptor, TRADD, followed by downstream executioners, caspase-3 and caspase-6. Unlike cisplatin, nedaplatin and oxaliplatin are highly neurotoxic when applied to cochlear cultures preferentially damaging auditory nerve fibers at low concentrations and hair cells at high concentrations. Carboplatin, considered far less ototoxic than cisplatin, is paradoxically highly toxic to chinchilla inner hair cells and type I spiral ganglion neurons; however, at high doses it also damages outer hair cells. Hair cell death from cisplatin and carboplatin is characterized in its early stages by upregulation of p53; blocking p53 expression with pifithrin-α prevents hair cell death. Major differences in the toxicity of these four platinum compounds may arise from several different metal transporters that selectively regulate the influx, efflux, and sequestration of these drugs. Anat Rec, 2012. © 2012 Wiley Periodicals, Inc.
Dalian Ding; Brian L Allman; Richard Salvi
Related Documents :
23523328 - Differential targeting of immune-cells by pixantrone in experimental myasthenia gravis.
24091428 - Poly(acrylic acid)-block-poly(vinyl alcohol) anchored maghemite nanoparticles designed ...
24007328 - A physiologically-based flow network model for hepatic drug elimination i: regular latt...
23112228 - An expanding role for cell biologists in drug discovery and pharmacology.
3923078 - Modification of the electrophysiologic matrix by antiarrhythmic drugs.
1425498 - Gamma-vinyl gaba (vigabatrin): clinical experience in adult and adolescent patients wit...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-8
Journal Detail:
Title:  Anatomical record (Hoboken, N.J. : 2007)     Volume:  -     ISSN:  1932-8494     ISO Abbreviation:  Anat Rec (Hoboken)     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101292775     Medline TA:  Anat Rec (Hoboken)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Center for Hearing and Deafness, 137 Cary Hall, University at Buffalo, Buffalo, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemi...
Next Document:  Treatment of colorectal cancer in older patients.